The results clarify the c‐Mpl distribution defects in the cell membrane and the corresponding c‐Mpl membrane transport mechanisms in megakaryocytes of ITP, providing new insights to improve the clinical efficacy of thrombopoietic agents for ITP patients. Here, MPL is linked to autoimmune thrombocytopenic purpura.